Cargando…

ALBI Score Is a Strong Predictor of Toxicity Following SIRT for Hepatocellular Carcinoma

SIMPLE SUMMARY: SIRT, also known as radioembolization, is a new treatment for hepatocellular carcinoma. However, the precise role is still not clearly determined. Here, we describe how a new score, ALBI, used to better assess liver functions, can help to select patients for this treatment. We clearl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lescure, Céline, Estrade, Florian, Pedrono, Maud, Campillo-Gimenez, Boris, Le Sourd, Samuel, Pracht, Marc, Palard, Xavier, Bourien, Héloïse, Muzellec, Léa, Uguen, Thomas, Rolland, Yan, Garin, Etienne, Edeline, Julien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345032/ https://www.ncbi.nlm.nih.gov/pubmed/34359695 http://dx.doi.org/10.3390/cancers13153794

Ejemplares similares

Patients’ Experience of Systemic Treatment of Hepatocellular Carcinoma: A Review of the Impact on Quality of Life
por: Muzellec, Léa, et al.
Publicado: (2021)

Tivozanib for hepatocellular carcinoma: not likely a new option
por: Estrade, Florian, et al.
Publicado: (2020)

(188)Re-SSS Lipiodol Radioembolization in HCC Patients: Results of a Phase 1 Trial (Lip-Re-01 Study)
por: Garin, Etienne, et al.
Publicado: (2023)

Dosimetric parameters predicting contralateral liver hypertrophy after unilobar radioembolization of hepatocellular carcinoma
por: Palard, Xavier, et al.
Publicado: (2017)

High impact of macroaggregated albumin‐based tumour dose on response and overall survival in hepatocellular carcinoma patients treated with (90)Y‐loaded glass microsphere radioembolization
por: Garin, Etienne, et al.
Publicado: (2016)

Selective Internal Radiation Combined with Chemotherapy Maintains the Quality of Life in Intrahepatic Cholangiocarcinomas
por: Goislard de Monsabert, Camille, et al.
Publicado: (2021)

Personalised Dosimetry in Radioembolisation for HCC: Impact on Clinical Outcome and on Trial Design
por: Garin, Etienne, et al.
Publicado: (2020)

Hepatocellular carcinoma in elderly patients: challenges and solutions
por: Brunot, Angélique, et al.
Publicado: (2016)

In albis : poemas, 1979-1990 /
por: Magaña, Gabriel, 1944-

Usefulness and pitfalls of MAA SPECT/CT in identifying digestive extrahepatic uptake when planning liver radioembolization
por: Lenoir, Laurence, et al.
Publicado: (2012)

Clinical impact of (99m)Tc-MAA SPECT/CT-based dosimetry in the radioembolization of liver malignancies with (90)Y-loaded microspheres
por: Garin, Etienne, et al.
Publicado: (2015)

Boosted selective internal radiation therapy with (90)Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept
por: Garin, E., et al.
Publicado: (2013)

Comparative evaluation of ALBI, MELD, and Child-Pugh scores in prognosis of cirrhosis: is ALBI the new alternative?
por: Fragaki, Maria, et al.
Publicado: (2019)

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres
por: Bouvry, C., et al.
Publicado: (2018)

Locoregional Treatment in Intrahepatic Cholangiocarcinoma: Which Treatment for Which Patient?
por: Bourien, Héloïse, et al.
Publicado: (2023)

Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
por: Liao, Jia-I, et al.
Publicado: (2023)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results
por: Pracht, M., et al.
Publicado: (2013)

Child Pugh and ALBI grade: past, present or future?
por: Rimini, Margherita, et al.
Publicado: (2020)

Público y privado : un acuerdo necesario / Emilio Albi.
por: Albi Ibáñez, Emilio
Publicado: (2000)

Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Combined APRI/ALBI score to predict mortality after hepatic resection
por: Starlinger, P, et al.
Publicado: (2021)

Utility of Quantitative (99m)Tc-MAA SPECT/CT for (90)yttrium-Labelled Microsphere Treatment Planning: Calculating Vascularized Hepatic Volume and Dosimetric Approach
por: Garin, Etienne, et al.
Publicado: (2011)

Application of the ALBI Scoring System for Mortality Outcome Prediction in Patients with Hypertrophic Cardiomyopathy
por: Qiao, Ping, et al.
Publicado: (2022)

Baseline ALBI Grade Predicts Benefits After Splenectomy for Cirrhotic Patients with Hypersplenism
por: Zhu, Qi, et al.
Publicado: (2023)

The ability of the new ALBI scoring in predicting mortality, complications and prognostic comparison among cirrhotics
por: Naqvi, Iftikhar Haider, et al.
Publicado: (2019)

ALBI grade: Evidence for an improved model for liver functional estimation in patients with hepatocellular carcinoma
por: Demirtas, Coskun O., et al.
Publicado: (2021)

An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma
por: He, Cheng, et al.
Publicado: (2022)

The Association of Albumin-Bilirubin (ALBI) Grade with Mortality Risk in Trauma Patients with Liver Injuries
por: Chou, Sheng-En, et al.
Publicado: (2023)

Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade
por: Toyoda, Hidenori, et al.
Publicado: (2016)

Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade
por: Pinato, David J., et al.
Publicado: (2020)

Ability of the post-operative ALBI grade to predict the outcomes of hepatocellular carcinoma after curative surgery
por: Cho, Wei-Ru, et al.
Publicado: (2020)

Effect of ramucirumab on ALBI grade in patients with advanced HCC: Results from REACH and REACH-2
por: Kudo, Masatoshi, et al.
Publicado: (2020)

Prognostic value of the ALBI grade among patients with single hepatocellular carcinoma without macrovascular invasion
por: Chen, Wenhao, et al.
Publicado: (2021)

The ALBI score: From liver function in patients with HCC to a general measure of liver function
por: Toyoda, Hidenori, et al.
Publicado: (2022)

Preoperative ALBI grade predicts mortality in patients undergoing curative surgery for pancreatic head cancer
por: Azili, Cem, et al.
Publicado: (2023)

Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)

Correlation and prognostic accuracy between noninvasive liver fibrosismarkers and portal pressure in cirrhosis: Role of ALBI score
por: Hsieh, Yun-Cheng, et al.
Publicado: (2018)

Prognostic Role of Albumin, Bilirubin, and ALBI Scores: Analysis of 1000 Patients with Hepatocellular Carcinoma Undergoing Radioembolization
por: Antkowiak, Mark, et al.
Publicado: (2019)

Impact of Baseline ALBI Grade on the Outcomes of Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Multicenter Study
por: Ueshima, Kazuomi, et al.
Publicado: (2019)

Albumin-bilirubin (ALBI) score at admission predicts possible outcomes in patients with acute-on-chronic liver failure
por: Chen, Bo, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rkjfnitqcktd7cbhlejfg441ob